The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
The role of short-chain fatty acids in microbiota–gut–brain communication
Open accessAbstract
Short-chain fatty acids (SCFAs), the main metabolites produced by bacterial fermentation of dietary fibre in the gastrointestinal tract, are speculated to have a key role in microbiota-gut-brain crosstalk. However, the pathways through which SCFAs might influence psychological functioning, including affective and cognitive processes and their neural basis, have not been fully elucidated. Furthermore, research directly exploring the role of SCFAs as potential mediators of the effects of microbiota-targeted interventions on affective and cognitive functioning is sparse, especially in humans. This Review summarizes existing knowledge on the potential of SCFAs to directly or indirectly mediate microbiota-gut-brain interactions. The effects of SCFAs on cellular systems and their interaction with gut-brain signalling pathways including immune, endocrine, neural and humoral routes are described. The effects of microbiota-targeted interventions such as prebiotics, probiotics and diet on psychological functioning and the putative mediating role of SCFA signalling will also be discussed, as well as the relationship between SCFAs and psychobiological processes. Finally, future directions to facilitate direct investigation of the effect of SCFAs on psychological functioning are outlined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The gut microbiota influences gut barrier and produce neurotransmitters, amino acids and microbial metabolites61.”
From Association between attention-deficit/hyperactivity disorders and intestinal disorders: A systematic review and Meta-analysis (2025) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“gut microbiota dysbiosis has been implicated in behavioral and neurologic pathologies, such as depression, Alzheimer's (AD) and Parkinson's (PD) diseases and autism spectrum disorder (ASD) (9, 21, 25–27).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“brain to gut signaling can directly affect the microbiota, either via immune system or gut functions such as motility, release of neurotransmitters and intestinal immune tone (12, 17, 21, 31).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the gut microbiota can interact with the CNS via gut modulation or directly via metabolites and endotoxin translocation from the lumen to the circulation (9, 17, 21).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“altered SCFA production has been demonstrated in a variety of neuropathologies (19, 21, 33–35).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“these SCFAs regulate the expression levels of tryptophan 5-hydroxylase 1, the enzyme involved in synthesis of serotonin, and tyrosine hydroxylase, which is involved in a rate-limiting step in the biosynthesis of dopamine, noradrenaline and adrenaline; therefore, producing an effect on brain neurochemistry (21, 55, 56, 116, 117).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microbial metabolites such as short chain fatty acids (SCFAs) exert beneficial effects on psychiatric disorders via the microbiota–gut–brain axis through humoral, hormonal, and immune pathways [12].”
From Effect of Supplementation with Probiotics in Patients with Schizophrenia: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SCFAs exert their physiological activities by acting as endogenous ligands for G-protein-coupled receptors (GPCRs), and modulating gene expression by inhibiting histone deacetylases (HDACs).282”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
The cited source says what the claim attributes to it.
In the citing paper
“SCFAs can modulate the levels of neurotransmitters and neurotrophic factors and regulate the expression of tryptophan 5-hydroxylase, the enzyme involved in the synthesis of serotonin, and tyrosine hydroxylase, the enzyme involved in the rate-limiting step in dopamine, noradrenaline, and adrenaline synthesis (18, 132, 164, 222).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [132]
The cited source says what the claim attributes to it.
In the citing paper
“Other pathways through which SCFAs can influence gutbrain communication and brain function include immune, endocrine, neuronal, vagal, and other humoral pathways (360).”
From Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health (2021) · cites this paper as [360]
The cited source says what the claim attributes to it.
In the citing paper
“growing evidence supports the idea that SCFAs also exert crucial physiological effects on several organs, including the brain (17, 20, 21).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“Accumulating evidence suggests that SCFAs that cross into the CNS have neuroactive properties.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“It was described that SCFAs may modulate the levels of neurotransmitters and neurotrophic factors.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
In the citing paper
“SCFAs are endogenous ligands for a subset of GPCRs, including GPR43 and GPR41, which were subsequently renamed as free fatty acid receptor 2 (FFAR2) and FFAR3, respectively.”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
In the citing paper
“Another important GPCR activated by SCFA is GPR109A, also known as hydroxycarboxylic acid receptor 2 (HCAR2), which is activated by butyrate and β-D-hydroxy butyrate.282”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
In the citing paper
“and intracellular SCFAs can influence gene expression via histone deacetylation (HDAC) inhibition (Dalile et al., 2019)”
From The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy (2023) · cites this paper as Dalile et al., 2019
In the citing paper
“Moreover, SCFAs are endogenous ligands of orphan G protein-coupled receptors (GPCRs)”
From The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy (2023) · cites this paper as Dalile et al., 2019
In the citing paper
“Altered SCFA production has also been demonstrated in a variety of neuropathologies (42, 116, 127, 130, 132, 292–295).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Self-citationCommensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Cited by
Sorted by citations
Items 301–400 of 1,008
Gut microbiota: A new target of traditional Chinese medicine for insomnia
Feng, W., Yang, Z., Liu, Y., Chen, R., Song, Z., Pan, G., Zhang, Y., Guo, Z., Ding, X., Chen, L., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114344 · Cited by 88
Xiao-hang, Q., Si-yue, C., & Tang, H. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.03.031 · Cited by 88
Li, N., Niu, L., Liu, Y., Wang, Y., Su, X., Xu, C., Sun, Z., Guo, H., Gong, J., & Shen, S. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02506-4 · Cited by 88
Johnstone, N., Milesi, C., Burn, O., van den Bogert, B., Nauta, A., Hart, K. H., Sowden, P. T., Burnet, P. W. J., & Kadosh, K. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-87865-w · Cited by 88
Qiu, Z., Qiao, Y., Zhang, B., Sun‐Waterhouse, D., & Zheng, Z. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12972 · Cited by 90
Guo, B., Zhang, J., Zhang, W., Chen, F., & Liu, B. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2272769 · Cited by 88
Xu, Q., Sun, L., Chen, Q., Jiao, C., Wang, Y., Li, H., Xie, J., Zhu, F., Wang, J., Zhang, W., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.002 · Cited by 87
The emerging role of microbiota-derived short-chain fatty acids in immunometabolism
Jasim, S. A., Opulencia, M. J. C., Ramírez‐Coronel, A. A., Abdelbasset, W. K., Abed, M. H., Markov, A. A., Al‐Awsi, G. R. L., Shamsiev, J. A., Hammid, A. T., Shalaby, M. N., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108983 · Cited by 90
Majumdar, A., Venkatesh, I. P. S., & Basu, A. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00803 · Cited by 86
Duan, W.-X., Wang, F., Liu, J., & Liu, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01123-9 · Cited by 91
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention
Thulasinathan, B., Suvilesh, K. N., Maram, S., Grossmann, E. M., Ghouri, Y. A., Teixeiro, E., Chan, J., Kaifi, J. T., & Rachagani, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2483780 · Cited by 88
Dietary nutrition for neurological disease therapy: Current status and future directions
Mao, X., Yin, X., Guan, Q.-W., Xia, Q., Yang, N., Zhou, H., Liu, Z., & Jin, W. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107861 · Cited by 85
Sun, Y., Zhang, Z., Cheng, L., Zhang, X., Liu, Y., Zhang, R., Weng, P., & Wu, Z. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110675 · Cited by 85
Preglej, T., & Ellmeier, W. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.05.001 · Cited by 86
He, N., Shen, G., Jin, X., Li, H., Wang, J., Xu, L., Chen, J., Cao, X., Fu, C., Shi, D., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106377 · Cited by 85
Epigenetic effects of short-chain fatty acids from the large intestine on host cells
Stein, R. A., & Riber, L. (2023) · microLife · doi:10.1093/femsml/uqad032 · Cited by 85
Zhu, G., Zhao, J., Wang, G., & Chen, W. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00652 · Cited by 84
Wang, C., Zheng, D., Weng, F., Jin, Y., & He, L. (2021) · Psychopharmacology · doi:10.1007/s00213-021-06025-0 · Cited by 84
Su, L., Zhang, M., Qi, H., Gao, Y., Yang, Y., Yun, H., Zhang, Q., Yang, X., Zhang, Y., He, J., et al. (2022) · Microbiome · doi:10.1186/s40168-021-01205-8 · Cited by 84
Association between intestinal microbiota and inflammatory bowel disease
Zhang, Y., Si, X., Yang, L., Wang, H., Sun, Y. Q., & Liu, N. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12255 · Cited by 84
Female reproductive tract-organ axes
Takada, K., Melnikov, V. G., Kobayashi, R., Komine‐Aizawa, S., Tsuji, N. M., & Hayakawa, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1110001 · Cited by 84
The Role of Diet and Gut Microbiota in Alzheimer’s Disease
Dissanayaka, D. M. S., Jayasena, V., Rainey‐Smith, S. R., Martins, R. N., & Fernando, W. M. A. D. B. (2024) · Nutrients · doi:10.3390/nu16030412 · Cited by 84
The functional roles of short chain fatty acids as postbiotics in human gut: future perspectives
Ragavan, M. L., & Hemalatha, S. (2023) · Food Science and Biotechnology · doi:10.1007/s10068-023-01414-x · Cited by 86
Insulin resistance as the molecular link between diabetes and Alzheimer's disease
Abdalla, M. M. I. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i7.1430 · Cited by 83
A biological framework for emotional dysregulation in alcohol misuse: from gut to brain
Carbia, C., Lannoy, S., Maurage, P., López‐Caneda, E., O’Riordan, K. J., Dinan, T. G., & Cryan, J. F. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00970-6 · Cited by 82
Magzal, F., Even, C., Haimov, I., Agmon, M., Asraf, K., Shochat, T., & Tamir, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-83389-5 · Cited by 82
Gut-brain axis: A matter of concern in neuropsychiatric disorders…!
Naveed, M., Zhou, Q.-G., Chu, X., Taleb, A., Meng, F. J., Ahmed, B., Zhang, Y., Fukunaga, K., & Han, F. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110051 · Cited by 82
Enteric Microbiota-Mediated Serotonergic Signaling in Pathogenesis of Irritable Bowel Syndrome
Mishima, Y., & Ishihara, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910235 · Cited by 81
Kotlyarov, S. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094768 · Cited by 81
Wheat bran as potential source of dietary fiber: Prospects and challenges
Saini, P., Islam, M., Das, R., Shekhar, S., Sinha, A. S. K., & Prasad, K. (2022) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2022.105030 · Cited by 81
Stress and the gut-brain axis: an inflammatory perspective
Morys, J., Małecki, A., & Nowacka-Chmielewska, M. M. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1415567 · Cited by 81
How microbiota shape microglial phenotypes and epigenetics
Erny, D., & Prinz, M. (2020) · Glia · doi:10.1002/glia.23822 · Cited by 80
Kong, Q., Wang, B., Tian, P., Li, X., Zhao, J., Zhang, H., Chen, W., & Wang, G. (2021) · Food & Function · doi:10.1039/d0fo02375b · Cited by 80
Gut microbiome in gastrointestinal cancer: a friend or foe?
Liu, Y., Baba, Y., Ishimoto, T., Gu, X. J., Zhang, J., Nomoto, D., Okadome, K., Baba, H., & Qiu, P. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69331 · Cited by 82
Butyrate and obesity: Current research status and future prospect
Peng, K., Dong, W., Luo, T., Tang, H., Zhu, W., Huang, Y., & Yang, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1098881 · Cited by 81
Modulation of the Gut Microbiota by Nutrition and Its Relationship to Epigenetics
Ferenc, K., Sokal-Dembowska, A., Helma, K., Motyka, E., Jarmakiewicz-Czaja, S., & Filip, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021228 · Cited by 80
Boonchooduang, N., Louthrenoo, O., Chattipakorn, N., & Chattipakorn, S. C. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02383-1 · Cited by 79
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy
Kalkan, H., Pagano, E., Paris, D., Panza, E., Cuozzo, M., Moriello, C., Piscitelli, F., Abolghasemi, A., Gazzerro, E., Silvestri, C., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216225 · Cited by 80
CRISPR-Cas-Based Engineering of Probiotics
Liu, L., Helal, S. E., & Peng, N. (2023) · BioDesign Research · doi:10.34133/bdr.0017 · Cited by 79
Gut microbiome and frailty: insight from genetic correlation and mendelian randomization
Cui, G., Li, S., Ye, H., Yang, Y., Jia, X., Lin, M., Chu, Y., Feng, Y., Wang, Z., Shi, Z., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2282795 · Cited by 79
Microbiota-Derived Short-Chain Fatty Acids Promote LAMTOR2-Mediated Immune Responses in Macrophages
Wu, T., Li, H., Su, C., Xu, F., Yang, G., Sun, K., Xu, M., Lv, N., Meng, B., Liu, Y., et al. (2020) · mSystems · doi:10.1128/msystems.00587-20 · Cited by 78
Dissecting ultra-processed foods and drinks: Do they have a potential to impact the brain?
Contreras‐Rodríguez, O., Solanas, M., & Escorihuela, R. M. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09711-2 · Cited by 78
Kim, N. Y., Lee, H. Y., Choi, Y. Y., Mo, S. J., Jeon, S., Ha, J. H., Park, S. D., Shim, J.-J., Lee, J., & Chung, B. G. (2024) · Nano Convergence · doi:10.1186/s40580-024-00413-w · Cited by 81
Ding, F., Wu, J., Liu, C., Bian, Q., Qiu, W., Ma, Q., Li, X., Long, M., Zou, X., & Chen, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01069 · Cited by 77
Wen, K., Tao, L., Tao, Z., Meng, Y., Zhou, S., Chen, J., Yang, K., Da, W., & Zhu, Y. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.535310 · Cited by 77
Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions
Borella, F., Carosso, A. R., Cosma, S. D., Preti, M., Collemi, G., Cassoni, P., Bertero, L., & Benedetto, C. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00839 · Cited by 77
Prokopidis, K., Giannos, P., Ispoglou, T., Witard, O. C., & Isanejad, M. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.03.022 · Cited by 77
Wu, Y., Wang, Y., Hu, A., Shu, X., Huang, W., Liu, J., Wang, B., Zhang, R., Yue, M., & Yang, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.946096 · Cited by 78
Host metabolic benefits of prebiotic exopolysaccharides produced by Leuconostoc mesenteroides
Miyamoto, J., Shimizu, H., Hisa, K., Matsuzaki, C., Inuki, S., Ando, Y., Nishida, A., Izumi, A., Yamano, M., Ushiroda, C., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2022.2161271 · Cited by 77
Qi, B., Ren, D., Li, T., Niu, P., Zhang, X., Yang, X., & Xiao, J. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c02400 · Cited by 76
Cuervo-Zanatta, D., Syeda, T., Sánchez-Valle, V., Irene-Fierro, M., Torres‐Aguilar, P. C., Torres-Ramos, M., Shibayama-Salas, M., Silva-Olivares, A., Noriega, L. G., Torres, N., et al. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01268-7 · Cited by 76
Zou, B., Li, J., Ma, R., Cheng, X.-Y., Ma, R.-Y., Zhou, T.-Y., Wu, Z., Yao, Y., & Li, J. (2023) · Aging and Disease · doi:10.14336/ad.2022.1127 · Cited by 76
Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer’s Disease
Zhu, G., Zhao, J., Zhang, H., Wang, G., & Chen, W. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.04.005 · Cited by 78
Dong, X.-L., Wang, X., Liu, F., Liu, X., Du, Z.-R., Li, R. W., Xue, C.-H., Wong, K.-H., Wong, W.-T., Zhao, Q., et al. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.180 · Cited by 75
The Gut Microbiome as a Regulator of the Neuroimmune Landscape
Yu, L. W., Agirman, G., & Hsiao, E. Y. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101320-014237 · Cited by 75
Gut microbiota signature in treatment-naïve attention-deficit/hyperactivity disorder
Richarte, V., Sánchez-Mora, C., Corrales, M., Fadeuilhe, C., Vilar-Ribó, L., Arribas, L., Garcia, E., Rosales-Ortiz, S. K., Arias-Vasquez, A., Soler-Artigas, M., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01504-6 · Cited by 75
Mitsou, E. K., Saxami, G., Stamoulou, E., Kerezoudi, E. N., Terzi, E., Koutrotsios, G., Bekiaris, G., Zervakis, G. I., Mountzouris, K. C., Pletsa, V., et al. (2020) · Molecules · doi:10.3390/molecules25122806 · Cited by 75
Emotional well-being and gut microbiome profiles by enterotype
Lee, S., Yoon, S.-H., Jung, Y., Kim, N., Min, U.-G., Chun, J., & Choi, I. (2020) · Scientific Reports · doi:10.1038/s41598-020-77673-z · Cited by 75
Gut Microbiome in Anesthesiology and Pain Medicine
Minerbi, A., & Shen, S. (2022) · Anesthesiology · doi:10.1097/aln.0000000000004204 · Cited by 78
Su, S., Wu, Y., Lin, Q. D., Zhang, L., Wang, D., & Hai, J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02675-9 · Cited by 76
Li, Y., Gao, Y., Farag, M. A., Gong, J., Su, Q., Cao, H., Zhang, W., Zhao, Y., & Wang, H. (2023) · Food Frontiers · doi:10.1002/fft2.309 · Cited by 75
Mechanisms of microbial–neuronal interactions in pain and nociception
Lagomarsino, V. N., Kostic, A. D., & Chiu, I. M. (2020) · Neurobiology of Pain · doi:10.1016/j.ynpai.2020.100056 · Cited by 74
Chen, H., Yang, H., Deng, J., & Fan, D. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07805 · Cited by 74
Cai, H., Wang, C., Qian, Y., Zhang, S., Zhang, C., Zhao, W., Zhang, T., Zhang, B., Chen, J., Liu, S., et al. (2021) · Human Brain Mapping · doi:10.1002/hbm.25419 · Cited by 74
Spichak, S., Donoso, F., Moloney, G. M., Gunnigle, E., Brown, J. R.-M., Codagnone, M. G., Dinan, T. G., & Cryan, J. F. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100318 · Cited by 74
Gesù, C. M. D., Matz, L. M., Bolding, I. J., Fultz, R., Hoffman, K. L., Marino, A., Petrosino, J. F., & Buffington, S. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111461 · Cited by 74
The human gut microbiome of athletes: metagenomic and metabolic insights
Fontana, F., Longhi, G., Tarracchini, C., Mancabelli, L., Lugli, G. A., Alessandri, G., Turroni, F., Milani, C., & Ventura, M. (2023) · Microbiome · doi:10.1186/s40168-023-01470-9 · Cited by 74
Boehme, M., Rémond-Derbez, N., Lerond, C., Lavalle, L., Keddani, S., Steinmann, M., Rytz, A., Dalile, B., Verbeke, K., Oudenhove, L. V., et al. (2023) · Nutrients · doi:10.3390/nu15143122 · Cited by 74
Self-citationSingh, J., Vanlallawmzuali, Singh, A. K., Biswal, S., Zomuansangi, R., Lalbiaktluangi, C., Singh, B. P., Singh, P. K., Vellingiri, B., Iyer, M., et al. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104068 · Cited by 71
Jia, M., Fan, Y., Ma, Q., Yang, D., Wang, Y., He, X., Zhao, B., Zhan, X., Qi, Z., Ren, Y., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03211-4 · Cited by 82
From taxonomy to metabolic output: what factors define gut microbiome health?
Wilmanski, T., Rappaport, N., Diener, C., Gibbons, S. M., & Price, N. D. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1907270 · Cited by 73
Dietary fibre and the gut–brain axis: microbiota-dependent and independent mechanisms of action
Torre, D. L., Verbeke, K., & Dalile, B. (2021) · Gut Microbiome · doi:10.1017/gmb.2021.3 · Cited by 74
Self-citationLi, Y., Xia, D., Chen, J., Zhang, X., Wang, H., Huang, L., Shen, J., Wang, S., Feng, Y., He, D., et al. (2022) · Poultry Science · doi:10.1016/j.psj.2022.101742 · Cited by 73
Jadhav, A., Jagtap, S., Vyavahare, S., Sharbidre, A. A., & Kunchiraman, B. N. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1268041 · Cited by 72
Yang, S., Qiao, J., Zhang, M., Kwok, L., Matijašić, B. B., Zhang, H., & Zhang, W. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.006 · Cited by 73
The potential role of mitochondria in the microbiota-gut-brain axis: Implications for brain health
Qiao, L., Yang, G., Wang, P., & Xu, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107434 · Cited by 73
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease
Heinzel, S., Aho, V. T. E., Suenkel, U., von Thaler, A., Schulte, C., Deuschle, C., Paulin, L. G., Hantunen, S., Brockmann, K., Eschweiler, G. W., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26128 · Cited by 72
Regulation of flagellar motility and biosynthesis in enterohemorrhagic Escherichia coli O157:H7
Sun, H., Wang, M., Liu, Y., Wu, P., Yao, T., Yang, W., Yang, Q., Yan, J., & Yang, B. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2110822 · Cited by 72
Gut/rumen-mammary gland axis in mastitis: Gut/rumen microbiota–mediated “gastroenterogenic mastitis”
Hu, X., He, Z., Zhao, C., He, Y., Qiu, M., Xiang, K., Zhang, N., & Fu, Y. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.02.009 · Cited by 72
Jing, Y., Yang, D., Bai, F., Wang, Q., Zhang, C., Yan, Y., Li, Z., Li, Y., Chen, Z., Li, J., et al. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00466-5 · Cited by 72
Gubert, C., Choo, J. M., Love, C. J., Kodikara, S., Masson, B. A., Liew, J. J. M., Wang, Y., Kong, G., Narayana, V. K., Renoir, T., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac205 · Cited by 71
How the brain fights fatty acids’ toxicity
Schönfeld, P., & Reiser, G. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105050 · Cited by 71
Huang, S., Hu, S., Liu, S., Tang, B., Liu, Y., Tang, L., Lei, Y., Zhong, L., Yang, S., & He, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2021.105992 · Cited by 71
Matisz, C. E., & Gruber, A. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.020 · Cited by 71
Microbial liberation of N-methylserotonin from orange fiber in gnotobiotic mice and humans
Han, N. D., Cheng, J., Delannoy-Bruno, O., Webber, D. M., Terrapon, N., Henrissat, B., Rodionov, D. A., Arzamasov, A. A., Osterman, A. L., Hayashi, D. K., et al. (2022) · Cell · doi:10.1016/j.cell.2022.06.004 · Cited by 71
Wang, P., Zhang, X., Zheng, X., Gao, J., Shang, M., Xu, J., & Liang, H. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06297 · Cited by 71
Roager, H. M., Stanton, C., & Hall, L. J. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2192151 · Cited by 73
Liu, X., Liu, Y., Liu, J., Zhang, H., Shan, C., Guo, Y., Gong, X., Cui, M., Li, X., & Tang, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382223 · Cited by 75
Citrus Polyphenols in Brain Health and Disease: Current Perspectives
Pontifex, M. G., Malik, M., Connell, E., Müller, M. M., & Vauzour, D. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.640648 · Cited by 71
Host and microbiota metabolic signals in aging and longevity
Zhou, Y., Hu, G., & Wang, M. C. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00837-z · Cited by 70
Gut microbiota bridges the iron homeostasis and host health
Xiao, L., Tang, R., Wang, J., Wan, D., Yin, Y., & Xie, L. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2302-5 · Cited by 70
Lorente-Picón, M., & Laguna, A. (2021) · Biomolecules · doi:10.3390/biom11030433 · Cited by 69
Recent advances in modulating the microbiome
Quigley, E. M. M., & Gajula, P. (2020) · F1000Research · doi:10.12688/f1000research.20204.1 · Cited by 69
Hassan, A., Din, A. U., Zhu, Y. S., Zhang, K., Li, T., Wang, Y., Xu, S.-C., Lei, H., Yu, X., & Wang, G. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10693-x · Cited by 69
Chen, H., Nie, Q., Hu, J., Huang, X., Yin, J., & Nie, S. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07871 · Cited by 69
Xu, B., Qin, W., Xu, Y., Yang, W., Chen, Y., Huang, J., Zhao, J., & Ma, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6221012 · Cited by 69
RetractedThe gut microbiota in pediatric multiple sclerosis and demyelinating syndromes
Tremlett, H. L., Zhu, F., Arnold, D. L., Bar‐Or, A., Bernstein, C. N., Bonner, C., Forbes, J. D., Graham, M., Hart, J., Knox, N., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51476 · Cited by 70
Wei, L., Singh, R., & Ghoshal, U. C. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm22008 · Cited by 71
Niu, M., Guo, H.-X., Cai, J.-W., & Meng, X. (2022) · Nutrients · doi:10.3390/nu14183671 · Cited by 70
Galactooligosaccharides: Synthesis, metabolism, bioactivities and food applications
Wang, K., Duan, F., Sun, T., Zhang, Y., & Lu, L. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2164244 · Cited by 69
Metadata
- Authors
- Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K.
- Affiliations
- KU Leuven (BE)
- Corresponding author
- Verbeke, Kristin
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2019-05-23
- Volume
- 16
- Issue
- 8
- Pages
- 461-478
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2946372752
- Cited by
- 3,357
- References
- 289
- Citations by year
- 2026: 631 · 2025: 685 · 2024: 567 · 2023: 511 · 2022: 429 · 2021: 334 · 2020: 174 · 2019: 25
- FWCI
- 21.30
- Type
- journal article
- Language
- en
- Open access
- green
- lirias.kuleuven.be
- Licence
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- short-chain fatty acids, microbiota-gut-brain axis, dietary fiber fermentation, gut microbiota, psychological functioning, emotional processing, cognitive processes, prebiotics, probiotics, microbiota-targeted interventions, immune signaling, hormone signaling, psychobiology
- MeSH terms
- Gastrointestinal Microbiome, Animals, Mental Disorders, Brain, Dietary Fiber, Disease Models, Animal, Fatty Acids, Volatile, Humans, Neural Pathways, Signal Transduction, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
